A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso

NCT00452088 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

45

Enrollment

NETWORK

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: MSP 3 Long Synthetic Peptide
BIOLOGICAL: Hepatitis B vaccine
BIOLOGICAL: Hepatitis B control vaccince

Sponsor

African Malaria Network Trust

Collaborators

[object Object]